Literature DB >> 8923099

Trihexyphenidyl (Artane) abuse in schizophrenic patients.

Z Zemishlany1, D Aizenberg, Z Weiner, A Weizman.   

Abstract

Trihexyphenidyl (THP) and other anticholinergics are liable to abuse by schizophrenic patients. Data concerning the incidence and characteristics of the abusers are scarce. In the present study an evaluation of 214 consecutive admissions of schizophrenic patients revealed 14 THP abusers, an incidence of 6.5%. The demographic and clinical variables of the THP abusers were compared with a randomized control group of 28 schizophrenic patients using the four-dimensional factors of the BPRS (Brief Psychiatric Rating Scale). No significant differences were found in demographic variables and comorbidity for antisocial personality disorder and other substances abuse. On admission, a trend towards more negative symptoms was detected among abusers. At discharge abusers had significantly higher mean BPRS scores and higher scores on the dimensional factor of hostile-suspiciousness. The results suggest that THP abuse is not rare among schizophrenic patients who may abuse anticholinergic agents to relieve negative symptoms and/or drug-induced Parkinsonism, or alternatively for its non-specific stimulant effects, on account of worsening of positive symptoms.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8923099     DOI: 10.1097/00004850-199609000-00007

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  5 in total

Review 1.  Acute dystonia induced by drug treatment.

Authors:  P N van Harten; H W Hoek; R S Kahn
Journal:  BMJ       Date:  1999-09-04

Review 2.  Neuropsychiatric effects of prescription drug abuse.

Authors:  Jason P Caplan; Lucy A Epstein; Davin K Quinn; Jonathan R Stevens; Theodore A Stern
Journal:  Neuropsychol Rev       Date:  2007-08-16       Impact factor: 7.444

3.  The use and potential abuse of anticholinergic antiparkinson drugs in Norway: a pharmacoepidemiological study.

Authors:  Pål Gjerden; Jørgen G Bramness; Lars Slørdal
Journal:  Br J Clin Pharmacol       Date:  2008-12-16       Impact factor: 4.335

Review 4.  Cholinergic circuits and signaling in the pathophysiology of schizophrenia.

Authors:  Joshua A Berman; David A Talmage; Lorna W Role
Journal:  Int Rev Neurobiol       Date:  2007       Impact factor: 3.230

Review 5.  Misuse of Anticholinergic Medications: A Systematic Review.

Authors:  Stefania Chiappini; Alessio Mosca; Andrea Miuli; Francesco Maria Semeraro; Gianluca Mancusi; Maria Chiara Santovito; Francesco Di Carlo; Mauro Pettorruso; Amira Guirguis; John Martin Corkery; Giovanni Martinotti; Fabrizio Schifano; Massimo Di Giannantonio
Journal:  Biomedicines       Date:  2022-02-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.